Skip to main content

Posts Tagged ‘Duchenne muscular dystrophy’

Giving Patients A Digital Voice As The FDA Reviews Sarepta’s NDA

If you’re in the biotech business, you’re likely closely following the Sarepta saga, or, at the very least, you’re hearing about it in passing because everyone around you is talking about it. Sarepta Therapeutics, a Cambridge, Massachusetts-based company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare, infectious and […]